Effective data interpretation is a habit, not a random event. By applying the seven habits outlined in this article, any otolaryngologist--regardless of the level of statistical knowledge or lack thereof--will be able to use data effectively. The seven habits are (I) check quality before quantity, (2) describe before you analyze, (3) accept the uncertainty of all data, (4) measure error with the right statistical test, (5) put clinical importance before statistical significance, (6) seek the sample source, and (7) view science as a cumulative process. The same habits apply whether interpreting one's own data, interpreting someone else's data, reviewing an unpublished manuscript for a journal, or reviewing a grant application for a funding agency. The basic principles that underlie these habits provide a systematic process for moving from observations to generalizations with predictable degrees of certainty--and uncertainty.
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pretation, regardless of the specific situation or statistical test to which they are applied. If we understand and apply these principles, we will be able to tackle the most complex data or analytic problem.
By applying the seven habits (Table 1 ) outlined in this article, any otolaryngologist--regardless of the level of statistical knowledge or lack thereof--will be able to use data effectively. One of Eisenhower's favorite maxims was "In preparing for battle I have always found that plans are useless, but planning is indispensable." With regard to the incipient data battle, statistical tests are the "plans," and the seven habits are the "planning." Whereas choosing the right statistical test is an important task, it is the end not the means-of a principle-centered approach to comprehensive data analysis. We do not have to be numerical wizards to use this approach; all we need are patience, persistence, and a few good habits to temper the clash of statistics with the human mind.
THE SEVEN HABITS OF HIGHLY EFFECTIVE DATA USERS
The seven habits that follow are the key to understanding data. They embody fundamental principles of epidemiology and biostatistics, which are developed in a logical and sequential fashion. Table 1 gives an overview of the seven habits and the corresponding principles and key words that compose them.
Habit 1: Check Quality Before Quantity
Bias is a four-letter word that is easy to ignore, but difficult to avoid. 2 A clinician who ignores bias when inter-preting data is like a prospective employer who takes an applicant's resume at face value. Similarly, being the world's fastest ladder climber matters little if one gets to the top only to find the ladder resting against the wrong wall. Checking quality before quantity means checking the data for bias--systematic error--before plunging ahead with statistical analysis. It also means checking references before believing a resume and checking the wall before climbing the ladder. In the words of biologist Ruth Hubbard, "Bias... often reveals more about the investigator than about the subject being researched." Data collected specifically for research ( Table 2 ) are likely to be accurate and unbiased; they reflect the true value of the attribute being measured. In contrast, data collected during routine clinical care will vary in quality depending on the specific methods applied. For example, data in a medical record review is often tainted by unintentional systematic errors from the reviewer abstracting the data. Errors, however, can be reduced by attention to detail; a protocol with unambiguous dataextraction forms, a data dictionary for precise definitions, and attention to interrater reliability will maximize accuracy. Consequently, the method of data collection must always be scrutinized.
Data from experimental studies are generally of higher quality than data from observational investigations. 3 Experiments are performed under carefully controlled conditions for the sole purpose of increasing knowledge. Common examples include animal research, basic science studies, and randomized controlled trials (RCTs). In an observational study, however, the compared treatments or exposures are not under the control of the investigator. This introduces numerous hidden biases, many of which cannot be estimated. Observational studies may be improved through welldefined inclusion and exclusion criteria, data collection by impartial observers, and adequate measurement of important baseline variables relevant to the effect under study (confounders). 4 The presence or absence of a control group has a profound influence on data interpretation ( Table 2 ). An uncontrolled study, no matter how elegant, is purely descriptive. 5 Nonetheless, authors of case series often delight in unjustified musings on efficacy, effectiveness, association, and causality. Without a control or comparison group, it is often impossible to distinguish natural history from treatment effects ( Table 3 ). In the words of Voltaire, "The art of medi-
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Aspect of data quality
How were the data originally collected? 9 Specifically for research 9 During routine clinical care Is the study experimental or observational? 9 Experimental study with conditions under direct control of the investigator 9 Observational study without intervention other than to record, classify, and analyze Is there a comparison or control group?
9 Comparative or controlled study with two or more groups 9 No comparison group What is the direction of study inquiry? 9 Prospective study in which subjects are identified and followed up before developing an outcome or disease 9 Retrospective study in which subjects are identified after developing an outcome or disease and their histories are then examined 9 Cross-sectional study of a defined population at a single time
Effect on data interpretation
Interpretation is facilitated by quality data collected according to an a priori protocol Interpretation is limited by the consistency, accuracy, availability, and completeness of the source records Low potential for bias; randomization reduces allocation bias, and blinding reduces ascertainment bias High potential for bias; systematic errors may occur during sample selection, treatment assignment, and measurement of exposures and outcomes (Table 3 ) may account for on average 70% of good to excellent outcomes in uncontrolled studies. 6 The potential for these effects is proportional to the novelty or impressiveness of the treatment given and the setting in which it is administered. Coincidentally, surgical subspecialists often administer novel treatments in impressive settings. Further, patients with chronic disease typically have fluctuating symptoms and seek medical care (and enroll in research studies) when symptoms are at their worst. Thus the next change is likely to be an improvement (independent of therapy), a phenomenon called regression to the mean.
When data from a comparison or control group are available, inferential statistics may be used to test hypotheses and measure associations. Causality may also be assessed when the study has a time-span component, either retrospective or prospective ( Table 2) .
Prospective studies measure incidence (new events), whereas retrospective studies measure prevalence (existing events). Unlike time-span studies, cross-sectional inquiries measure association, not causality. Examples include surveys, screening programs, and evaluations of diagnostic tests. Experimentally planned interventions are ideal for assessing cause effect relations, because observational studies are prone to innate distortions or biases caused by individual judgments and other selective decisions. 7 Another clue to data quality is study type, 8 but this cannot replace the four questions in Table 2 . Note the variability in data quality for the study types listed in Table 4 , particularly the observational designs. Randomization balances baseline prognostic factors (known and unknown) among groups, including severity of illness and the presence of comorbid conditions. Because these factors also influence a clinician's decision to offer treatment, nonrandomized studies are prone to allocation (susceptibility) bias (Table 3) and false-positive results. 9 A typical example occurs when the survival of surgically treated cancer patients is compared with that of nonsurgical controls (e.g., radiation or chemotherapy). Without randomization, the surgical group will generally have a more favorable prognosis--independent of therapy--because the customary criteria for operability (special anatomic conditions and no major comorbidity) also predispose to favorable results.
The relation between data quality and interpretation is illustrated in Table 5 by using hypothetical studies to determine whether tonsillectomy causes baldness. Note , however, require adjustment for potential confounding variables, baseline prognostic factors that may be associated with both tonsillectomy and baldness and therefore influence results. As noted previously, adequate randomization ensures balanced allocation of prognostic factors among groups, thereby avoiding the issue of confounding. A dangerous habit is to label all data from RCTs high quality and all data from observational studies (e.g., outcomes research) substandard. In spite of the previously noted virtues of randomization, all RCTs do not necessarily yield high-quality data. Randomization can-not compensate for imprecise selection criteria, poorly defined end points, inadequate follow-up, or low compliance with treatment. More meaningful data would come from a protocol-driven controlled, observational study with unambiguous selection criteria, valid and reliable outcome definitions, and measures that foster compliance and follow-up. Data do not descend magically from Mount Olympus; they are crafted by mere mortals with varying degrees of veracity. Whether reading an RCT or an outcomes study, the methods for collecting the data must be scrutinized for validity, consistency, and reproducibility.
By checking quality before quantity, no time will be wasted interpreting uninterpretable data. As Thomas Huxley observed "Mathematics may be compared to a mill of exquisite workmanship, which grinds your stuff to any degree of fineness; but nevertheless, what you get out depends on what you put in--pages of formulae will not get a definite result out of loose data." Please review Tables 2 through 5 before proceeding, with par-
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Study execution Interpretation
A group of bald subjects are questioned as to whether or not they ever had tonsillectomy A group of subjects who had, or who are about to have, tonsillectomy are examined later for baldness A group of subjects are examined for baldness and for presence or absence of tonsils at the same time A group of bald subjects and a group of nonbald subjects are questioned about prior tonsillectomy A group of subjects who had prior tonsillectomy and a comparison group with intact tonsils are examined later for baldness A group of nonbald subjects about to have tonsillectomy and a nonbald comparison group with intact tonsils are examined later for baldness A group of nonbald subjects with intact tonsils are randomly assigned to tonsillectomy or observation and examined later for baldness
Measures prevalence of tonsillectomy in bald subjects; cannot assess association or causality Measures incidence of baldness after tonsillectomy; cannot assess association or causality Measures prevalence of baldness and tonsillectomy and their association; cannot assess causality Measures prevalence of baldness and association with tonsillectomy; limited ability to assess causality Measures incidence of baldness and assocition with tonsillectomy; can assess causality when adjusted for confounding variables Measures incidence of baldness and association with tonsillectomy; can assess causality when adjusted for confounding variables Measures incidence of baldness and association with tonsillectomy; can assess causality in spite of baseline confounding variables *Studies are listed in order of increasing ability to establish causal relation.
ticular attention to the examples in Table 5 . Knowing how to identify "loose data" must precede any attempt to describe or analyze the data set.
Habit 2: Describe Before You Analyze
Statistical tests often make assumptions about the underlying data. Unless these assumptions are met, the test will be invalid. Describing before you analyze avoids trying to unlock the mysteries of square data with a round key.
Describing data begins by defining the measurement scale that best suits the observations. Categoric (qualitative) observations fall into one or more categories, and include dichotomous, nominal, and ordinal scales ( Table 6 ). Numeric (quantitative) observations are measured on a continuous scale and are further classified by the underlying frequency distribution (plot of observed values vs the frequency of each value). Numeric data with a symmetric (normal) distribution are evenly placed around a central crest or trough (bell-shaped curve). Numeric data with an asymmetric distribution are skewed (shifted) to one side of the center, have a sloping "exponential" shape that resembles a forward or backward J, or contain some unusually high or low outlier values.
Depending on the measurement scale, data may be summarized by using one or more of the descriptive statistics in Table 7 . Note that when summarizing numeric data, the descriptive method varies according to the underlying distribution. Numeric data with a symmetric distribution are best summarized with the mean and standard deviation (SD), because 68% of the observations are within the mean + 1 SD and 95% are within the mean + 2 SD. In contrast, asymmetric numeric data are best summarized with the median, because even a single outlier can strongly influence the mean. For example, if five patients are followed up after sinus surgery for 10, 12, 15, 16, and 48 months, the mean duration of follow-up is 20 months, but the median is only 15 months. In this case a single outlier, 48 months, distorts the mean.
Although the mean is appropriate only for numeric data with a symmetric distribution, it is often applied regardless of the underlying symmetry. An easy way to determine whether the mean or median is appropriate for numeric data is to calculate both; if they differ significantly, the median should be used. Another way is to examine the standard deviation; when it is very large (e.g., larger than the mean value with which it is associated), the data often have an asymmetric distribution and should be described by the median and interquartile range. When in doubt, the median should always be used instead of the mean. 1~
A special form of numeric data is called censored (Table 6 ). Data are censored when three conditions apply: (1) the direction of study inquiry is prospective, of interest when the study ends. Interpreting censored data is called survival analysis, because of its use in cancer studies in which survival is the outcome of interest. Survival analysis permits full utilization of censored observations, by including them in the analysis up to the time the censoring occurred. If censored observations are instead excluded from analysis (e.g., exclude all patients with < 3 years' follow-up in a cancer study), the resulting survival rates will be biased, and sample size will be unnecessarily reduced.
Although censored observations are common in biomedical studies, survival analysis is underutilized by otolaryngologists, u Censored data occur in most studies in which time to event is the outcome of interest, unless 100% follow-up occurs over a prolonged period. Effective use of survival analysis in noncancer studies includes estimating the recurrence rate for surgically treated cholesteatoma (censored patients are lost to follow-up or disease free when the study ends), 12 estimating the time to natural resolution of congenital sublottic stenosis (censored patients are lost, have surgical correction, or have not yet resolved when the study ends), 13 or comparing the bacteriologic efficacy of antibiotics for pneumococcal otitis media in chinchillas (censored animals die or remain culture positive when the study ends). 14 In each of these examples, survival analysis could estimate the median time to event, as well as time-related event rates for any desired interval (e.g., 7-day, 1-year, 10-year). Censored data should never be described by using the mean, because they tend to have a strongly asymmetric distribution.
The odds ratio, relative risk, and rate difference ( Table 7) are useful ways of comparing two groups of dichotomous data. 15 A retrospective (case control) study of tonsillectomy and baldness might report an odds ratio of 1.6, indicating that bald subjects were 1.6 times more likely to have had tonsillectomy than were nonbald controls. In contrast, a prospective study would report results by using relative risk. A relative risk of 1.6 means that baldness was 1.6 times more likely to develop in tonsillectomy subjects than in nonsurgical controls. Finally, a rate difference of 30% in a prospective trial or experiment reflects the increase in baldness caused by tonsillectomy, above and beyond what occurred in controls. No association exists between groups when the rate difference equals zero, or the odds ratio or relative risk equals one (unity).
Two groups of ordinal or numeric data are compared with a correlation coefficient (Table 7) . A Coefficient (r) from 0 to 0.25 indicates little or no relation, from 0.25 to 0.50, a fair relation, from 0.50 to 0.75, a moderate to good relation, and greater than 0.75, a good to excellent relation. A perfect linear relation would yield a coefficient of 1.00. When one variable varies directly with the other, the coefficient is positive; a negative coefficient implies an inverse association. Sometimes the correlation coefficient is squared (}?2) to form the coefficient of determination, which estimates the percentage of variability in one measure that is predicted by the other. For example, if operative time shows an excellent correlation with blood loss (r = 0.80). then we could predict 64% (R2) of the variability in blood loss by knowing the operative time.
When interpreting a large number of observations, the easiest way to describe the data is by using a statistical computer program. Any statistical package can describe data graphically or numerically, making it easy to assess the underlying distribution and choose appropriate descriptive measures (Table 7) . For interpreting biomedical data, I highly recommend TRUE EPISTAT (Epistat Services, Richardson, Tex.), a personal computer program written by a physician for other physicians. The package includes many functions that are difficult (or impossible) to perform in general statistical programs, such as survival analysis, epidemiologic outcome measures (e.g., relative risk, odds ratio, rate dif- terence), confidence intervals, power curves, samplesize estimation, logistic regression, meta-analysis, and decision analysis.
Habit 3: Accept the Uncertainty of All Data
Nearly 2,000 years ago Pliny the Eider reported with certainty, "The only certainty is that nothing is certain." Accepting uncertainty--Habit 3--is the key to understanding medical data.
Uncertainty is present in all data because of the inherent variability in biologic systems and in our ability to assess them in a reproducible fashion. If hearing is measured in 20 healthy volunteers on 5 different days, how likely would it be to get the same mean result each time? Very unlikely, because audiometry has a variable behavioral component that depends on the subject's response to a stimulus and the examiner's perception of that response. Similarly, if hearing is measured in five groups of 20 healthy volunteers each, how likely would it be to get the same mean hearing level in each group? Again unlikely, because of variations between individuals. We would get a range of similar results, but rarely the same result on repetitive trials.
Uncertainty must be dealt with when interpreting data, unless the resuits are meant to apply only to the particular group of patients, animals, cell cultures, DNA strands, and so on, in which the observations were initially made. Recognizing this uncertainty, we call each of the descriptive measures in Table 7 a point estimate, specific to the data that generated it. In medicine, however, we seek to pass from observations to generalizations and from point estimates to estimates about other populations. When this process occurs with calculated degrees of uncertainty, we call it inference.
Here is a brief example of clinical inference. After treating five vertiginous patients with vitamin C, you remark to a colleague that four had excellent relief of their vertigo. She asks, "How confident are you of your results?" "Quite confident," you reply, "there were five patients, four got better, and that's 80%." "Maybe I wasn't clear," she interjects, "how confident are you that 80% of vertiginous patients you see in the next few weeks will respond favorably, or that 80% of similar patients in my practice will do well with vitamin C?" "In other words," she continues, "can you infer anything about the real effect of vitamin C on vertigo from only five patients?" Hesitatingly you retort "I'm pretty confident about that number 80%, but maybe I'll have to see a few more patients to be sure."
The real issue, of course, is that a sample of only five patients offers low precision (repeatability). How likely is it that the same results would be found if five new patients were studied? Actually, we can state with 95% confidence that four of five success in a single trial is
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Volume 1 ] 8 Number 2 Precision may be increased (uncertainty may be decreased) by using a more reproducible measure, by increasing the numbe r of observations (sample size), or by decreasing the variability among the observations. The most common method is to increase the sample size, because we can rarely reduce the variability inherent in the subjects we study. Even a huge sample of perhaps 50,000 subjects still has some degree of uncertainty, but the 95% confidence interval will be quite small. Realizing that uncertainty can never completely be avoided, we use statistics to estimate precision. Thus when data are described by using the summary measures listed in Table 7 , a corresponding 95% confidence interval should accompany each point estimate.
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Precision differs from accuracy. Precision relates to random error and measures repeatability; accuracy relates to systematic error (bias) and measures nearness to the truth. A precise otologist may always perform a superb mastoidectomy, but an accurate otologist performs it on the right patient. A precise surgeon cuts on the exact center of the line, but an accurate surgeon first checks the line to be sure it is in the fight place. Succinctly put, precision is doing things fight and accuracy is doing the right thing. Precise data include a large enough sample of carefully measured observations to yield repeatable estimates; accurate data are measured in an unbiased manner so that they reflect what is truly purported to be measured. When interpreting data, we must estimate both precision and accuracy.
Before moving on to Habit 4, let me briefly summarize Habits 1, 2, and 3. Habit 1, "Check quality before quantity," determines whether or not the data are worth interpreting. Assuming they are, we move to Habit 2, "Describe before you analyze," and summarize the data by using appropriate measures of central tendency, dispersion, and outcome for the particular measurement scate(s) involved. Next, we "Accept the uncertainty of all data" as noted in Habit 3, and qualify the point estimates in Habit 2 with 95% confidence intervals to measure precision. When precision is low (e.g., the confidence interval is wide), we proceed with caution. Otherwise, we proceed with Habits 4, 5, and 6, which deal with errors and inference.
Habit 4: Measure Error with the Right Statistical Test
"The study of error is not only in the highest degree prophylactic," observes Walter Lippman, "but it serves as a stimulating introduction to the study of truth." To err is human--and statistical. When we compare two or more groups of uncertain data, errors in inference are inevitable. If we conclude the groups are different, they may actually be equivalent. If we conclude they are the same, we may have missed a true difference. The ignorant data analyst ignores the possibility of error; the savvy analyst estimates this possibility by using the fight statistical test) 9 Now that we have stated the problem in English, let us restate it in thoroughly confusing statistical jargon (Table 8 ). We begin with some testable hypothesis about the groups we are studying, such as "Gibberish levels in group A differ from those in group B." Rather than keep it simple, we now invert this to form a null hypothesis) "Gibberish levels in group A are equal to those in group B." Next we fire up our personal computer, enter the gibberish levels for the subjects in both groups, choose an appropriate statistical test, and wait for the omnipotent p value to emerge.
The p value tells us the probability making a type I error." rejecting a true null hypothesis, In other words, ifp = 0.10 we have a 10% chance of being wrong (false positive) when we declare group A differs from group B. Alternatively, there is a 10% probability that the difference in gibberish levels is explainable by random error; we cannot be certain that uncertainty is not the cause. In medicine, p < 0.05 is generally considered low enough safely to reject the null hypothesis. Conversely, when p > 0.05, we accept the null hypothesis of equivalent gibberish levels. Nonetheless, we may be making a type H error by accepting a false null hypothesis (false negative). Rather than state the probability of a type II error directly (which would make too much sense), we state it indirectly by specifying power (Table 8) . Clear as mud, right?
Now let us digress from principles to practice. We shall use two hypothetical studies for this purpose. The first is an observational, prospective study to determine whether tonsillectomy causes baldness: 20 patients undergoing tonsillectomy and 20 controls are examined 40 years later, and the incidence of baldness is compared. The second study will use the same groups but will determine whether tonsillectomy causes hearing loss. This will allow us to explore statistical error from the perspective of a dichotomous outcome (bald vs nonbald) and a numeric outcome (hearing level in decibels).
Suppose that baldness develops in 16 (80%) of 20 patients after tonsillectomy but in only 50% of controls (10 of 20). If we infer that, based on these results in 40 specific patients, tonsillectomy predisposes to baldness, in general, what is our probability of being wrong (type I error)? Because p = 0.10 (Fisher's exact test) there is a 10% chance of type I error, so we are reluctant to associate tonsillectomy with baldness from this single study. In the words of Thomas Huxley we have just witnessed "The great tragedy of Science: the slaying of a beautiful hypothesis by an ugly fact."
Intuitively, however, a rate difference of 30% seems meaningful, so what is our chance of being wrong when we conclude it is not significant (type II error)? The probability of a type II error (false-negative result) is actually 48% (same as saying 52% power), which means we may indeed be wrong in accepting the null hypothesis. 2~ Actually, an interesting sideline to measuring error is the concept of sam--ple size. Calculating sample size before beginning a study ensures that the planned number of observations will offer a reasonable chance (power) of obtaining a clear answer at the end. 21 '22 The basic ingredients needed to calculate sample size include the smallest difference that must be detected between the groups, the limit of tolerance for a type I error (typically 5% or 1%), and the limit of tolerance for a type II error (typically 20% or 10%). Intrigued by our initial findings, we perform a sample size calculation and repeat the tonsillectomy study with twice as many patients in each group. Suppose that baldness again develops in 32 (80%) of 40 patients after tonsillectomy but in only 20 (50%) of 40 controls. The rate difference is still 30%, but now p = 0.01 (Fisher's exact test). We therefore conclude that tonsillectomy is associated with baldness, with only a 1% chance of making a type I error (false-positive result). By increasing the number of subjects studied, we increased precision to a level at which we could move from observation to generalization with a tolerable level of uncertainty.
Returning to our earlier study of 20 tonsillectomy patients and 20 controls, we find that the hearing levels for the groups are 25 + 9 decibels (dB) and 20 + 9 dB, respectively (mean value + SD). What is our chance of being wrong if we infer that posttonsillectomy patients have hearing levels 5 dB lower than controls? Because p = 0.09 (t test), there is a 9% probability of a type I error. If, however, we conclude there is no true difference between the groups, we have a 58% chance of making a type II error. Thus we can say little about the impact of tonsillectomy on hearing from this study, because power is only 42%. In general, studies with "negative" findings should be interpreted by power and not by p values.
When making inferences about numeric data, precision may be increased by studying more subjects or subjects with less variability in their responses. For example, suppose that we again study 20 patients with tonsillectomy and 20 controls, but this time the heating levels are 25 + 3 dB and 20 + 3 dB. Although the difference remains 5 dB, the standard deviation is only 3 for this study compared with 9 for the preceding paragraph. For whatever reason, the second subjects had more consistent (less variable) responses. What effect does this reduced variability have on our ability to make inferences? We now obtain p < 0.001 (t test), indi-cating less than a I:1000 probability of a type I error if we conclude that the hearing levels truly differ.
All statistical tests measure error. Choosing the right test for a particular situation (Tables 9 and 10) is determined by (1) whether the observations come from independent or related samples, (2) whether the purpose is to compare groups or to associate an outcome with one or more predictor variables, and (3) the measurement scale of the variables. In spite of the myriad tests available, the principles underlying each remain constant.
Two events are independent if the occurrence of one is in no way predictable from the occurrence of the other. A common example of independent samples is two or more parallel (concurrent) groups in a clinical trial or observational study. Conversely, related samples include paired organ studies, subjects matched by age and sex, and repeated measures on the same subjects (e.g., before and after treatment). Measurement scales were previously discussed, but the issue of frequency distribution deserves reemphasis. The tests in Tables 9 and 10 labeled "parametric" assume an underlying symmetric distribution for data. If the data are sparse, asymmetric, or plagued with outliers, then a "nonparametric" test must be used.
Using the wrong statistical test to estimate error invalidates results. For example, suppose we measure intelligence quotient (IQ) in 20 subjects before and after tonsillectomy, and find that the mean IQ increases from 125 to 128. For this 3-point increase, p = 0.29 (t test, independent samples), suggesting a high probability (29%) of reaching a false-positive conclusion. However, the observations in this example are related: before and after IQ tests in the same subjects. What is really of interest is the mean change in IQ for each subject (related samples), not how the mean IQ of all subjects before surgery compares with the mean IQ of all subjects after surgery (independent samples). When the proper statistical test is used (t test, paired samples), p = 0.05, suggesting a true association. Related (matched) samples are common in biomedical studies
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February 1998 Entire colleciton of items, subjects, patients, observations, etc., about which we want to make inferences: defined by the selection criteria (inclusion and exclusion criteria) for the study Subset of the target population accessible for study, generally because of geographic or temporal considerations Subset of the accessible population chosen for study Process of choosing a sample from a larger population; the method may be random or nonrandom, representative or nonrepresentative Error caused by systematic differences between a study sample and target population; examples include studies on volunteers and those conducted in clinics or tertiary care settings Process of deciding, before a study begins, how many subjects should be studied; based on the incidence or prevalence of the condition under study, anticipated differences between groups, the power that is desired, and the allowable level of type I error Degree to which conclusions drawn from a study are valid for the study sample; results from proper study design, unbiased measurements, and sound statistical analysis Degree to which conclusions drawn from a study are valid for a target population (beyond the subjects in the study); results from representative sampling and appropriate selection criteria and should never be analyzed as though they were independent.
A fundamental assumption underlying all statistical tests is that the hypothesis under study was fully developed before the data were examined in any way. When hypotheses are formulated, post hoc, after even the briefest glance at the data, the basis for probability statements is invalidated. Consider, for example, the Texas sharpshooter who shoots an arrow at a barn wall, and then meticulously draws a bull's eye around it. When his friends later arrive, they applaud his incredible accuracy. Similarly, we have no way of knowing at which stage of the research process a hypothesis was developed. Data that are tortured sufficiently will eventually confess to something (e.g., a post hoc hypothesis is born).
As physician-friendly computer programs for statistical analysis continue to proliferate, more physicians are likely to analyze their own data. Unless the probability framework underlying hypothesis tests is understood and appreciated (Habits 3 and 4) , the risk of post hoc p values will increase dramatically as they become easier to produce. When the primary research purpose is to test an a priori hypothesis, the p value will aid in statistical inference. When hypotheses are generated after the study, however, p values cannot be used to make inferences. Instead they become a means of identifying promising associations that might form the new a priori hypotheses in a follow-up investigation.
Habit 5: Put Clinical Importance Before Statistical Significance
Results are statistically significant when the probability of a type 1 error is low enough (p < 0.05) safely to reject the null hypothesis. If the statistical test compared two groups, we conclude that the groups differ. If the statistical test compared three or more groups, we conclude that there are global differences among them. If the statistical test related predictor and outcome variables (regression analysis), we conclude that the predictor variables explain more variation in the outcome than would be expected by chance alone. These generalizations apply to all the statistical tests in Tables 9 and 10 .
The next logical question after "Is there a difference?" (statistical significance) is "How big a difference is there?" (clinical importance). Unfortunately, most data interpretation stops with the p value, and the second question is never asked. For example, a recent clinical trial of nonsevere acute otitis media found amoxicillin superior to placebo as initial treatment (p = 0.009). 23 Before we agree with the author's recommendation for routine amoxicillin therapy, let us look more closely at the magnitude of clinical effect. Initial treatment success occurred in 96% of amoxicillin-treated children versus 92% of controls, yielding a 4% rate difference favoring drug therapy. Alternatively, we must treat 25 subjects (100/4) with amoxicillin to increase the success rate by one subject over what would occur from placebo alone. Is this clinically important? Maybe, or maybe not.
Statistically significant results must be accompanied by a measure of effect size, which reflects the magnitude of difference between groups. 24 Otherwise findings with minimal clinical importance may become statistically significant when a large number of subjects are studied.
In the previous example, the 4% difference in success rates was highly statistically significant because more than 1000 episodes of otitis media were analyzed. Large numbers provide high precision (repeatability), which in turn reduces the likelihood of error. The final result is a (Table 7) . For example, in the hypothetical study of tonsillectomy and baldness, the rate difference was 30% (p = 0.01), with a 95% confidence interval of 10% to 50%. Therefore we are 95% confident that tonsillectomy increases the rate of baldness between 10% and 50%, with only 1% chance of a type I error (false positive). Alternatively, results could be expressed in terms of relative risk. For the tonsillectomy study, relative risk is 1.6 (the incidence of baldness was 1.6 times higher after surgery), with a 95% confidence interval of 1.1 to 2.3. Effect size and 95% confidence limits may be calculated manually 25,26 or with a computer program. 17 Effect size is measured by the correlation coefficient (r) when an outcome variable is associated with one or more predictor variables in a regression analysis ( Table  9 ). Suppose that a study of thyroid surgery reports that shoe size had a statistically significant association with thyroxine levels (multiple linear regression, p = 0.04, r = 0.10). A correlation of only 0.10 implies little or no relation (see "Describe before you analyze"), and an R2 of 0.01 means that only 1% of the variance in thyroxine levels is explainable by shoe size. Who cares if the results are "significant" when the effect size is clinically irrelevant, not to mention nonsensical. Besides, when p = 0.04, we have a 4% chance of being wrong when we reject the null hypothesis, which may in fact be the case here. A nonsensical result should prompt a search for confounding factors that may not have been included in the regression, such as tumor/metastasis/node (TMN) stage, comorbid conditions, duration of surgery, and so on.
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Confidence intervals are more appropriate measures of clinical importance than are p values, because they reflect both magnitude and precision. 16, 27 For example, a recent clinical practice guideline on otitis media with effusion discouraged steroid-antibiotic therapy because the combined results from three randomized trials were not statistically significant. 28 Nonetheless, therapy boosted cure rates by 25% (rate difference) with a 95% confidence interval of-1% to 50%. Although not statistically significant (the confidence interval contains zero), the data are consistent with a rate difference up to 50%--a potentially important result. The broad confidence interval suggests low precision and a high probability of a type II error (low power). Therefore rather than discard steroid-antibiotic therapy as useless because p > 0.05, we conclude that more studies are needed to determine whether an important clinical benefit may have been missed. Sherlock Holmes once remarked "From a drop of water a logician could infer the possibility of an Atlantic or a Niagara without having seen or heard of one or the other." Habit 5, however, urges greater caution when making inferences about a drop (or 10,000 drops) of medical data. The effective data user never allows logic (statistical significance) to supersede good judgment (clinical importance).
Habit 6: Seek the Sample Source
When we interpret medical data, we ultimately seek to make inferences about some target population from results in a smaller sample (Table 11 ). Rarely is it possible to study every patient, medical record, DNA strand, or fruit fly with the condition of interest, nor is it necessary. Inferential statistics allow us to generalize from the few to the many, provided that the few we study are a random and representative sample of the many. However, random and representative samples 156 ROSENFELD
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As an example of sampling, consider a new antibiotic that is touted as superior to an established standard for treating acute otitis media. When we review that data on which this statement is based, we learn that the study end point was bacteriologic efficacy--the ability to sterilize the middle ear after treatment. Further, the only patients included in the study were those whose initial tympanocentesis revealed an organism with in vitro sensitivity to the new antibiotic; patients with no growth or resistant bacteria were excluded. Can we apply these results to clinical practice? Most likely not, because most clinicians probably do not limit their practice to patients with sensitive bacteria. In other words, the sample of patients included in the study is not representative of the target population.
A statistical test is valid only when the study sample is random and representative. Unfortunately, these assumptions are frequently violated or overlooked. A random sample is necessary because most statistical tests are based on probability theory: playing the odds. The odds apply only if the deck is not stacked and the dice are not rigged; that is, all members of the target population have an equal chance of being sampled for study. Investigators, however, typically have access to only a small subset of the target population because of geographic or temporal constraints. When they choose an even smaller subset of this accessible population to study, the method of choosing (sampling method) affects their ability to make inferences about the original target population. Of the sampling methods listed in Table 12 , only a random sample is theoretically suitable for statistical analysis. Nonetheless, a consecutive or systematic sample offers a relatively good approximation and provides data of sufficient quality for most statistical tests. The worst sampling method occurs when subjects are chosen for convenience or from subjective judgments about eligibility. Applying statistical tests to the resulting convenience (grab) sample is the equivalent of asking a professional card counter to help win a blackjack game when the deck is stacked deck and cards are missing--all bets are off because probability theory will not apply. A brute-force sample of the entire population is also unsatisfactory, because lost, missing, or incomplete units tend to differ systematically from those that are readily accessible.
"Seek the sample source" means identifying the sampling method and selection criteria (inclusion and exclusion criteria) that were applied to the target popu-lation to obtain the study sample. When the process appears sound, we conclude that the results are generalizable and externally valid (Table 11 ). If the process appears flawed, we cannot interpret or extrapolate the results beyond the confines of the study sample. For example, a nasal spray that is effective for tree-pollen allergy in patients referred to a tertiary rhinology center would offer uncertain benefit for patients with dust mite allergy treated by a family practitioner. Similarly patients studied by otolaryngologists generally have more severe and chronic disease than the population at large or the population seen by primary care physicians. Volunteers and hospital-based patients are further examples of biased samples with potentially low generalizability.
The impact of sampling on generalizability is particularly important when interpreting a diagnostic test. 29 For instance, suppose an audiologist develops a new test for diagnosing middle ear effusion (MEE). After testing 1000 children, she reports that 90% of children with a positive result did in fact have MEE (positive predictive value of 90%). Yet on screening unselected kindergarten children for MEE, the positive predictive value of the test is only 50%. Why does this occur? Because the baseline prevalence of MEE is lower in the kindergarten class (10% have MEE) than in the referral-based audiology population in which the test was developed (50% have MEE). Whereas the sensitivity and specificity of the test are unchanged in both situations, the predictive value is related to baseline prevalence (Bayes' theorem). Therefore, the ultimate utility of the test depends on the sample to which it will be applied.
As Walter Lippman once observed, "The tendency of the casual mind is to pick out or stumble upon a sample which supports or defies its prejudices, and then to make it representative of a whole class." Although Lippman was a journalist, his insight applies equally well to medical data. Biased and prejudicial samples become defenseless when we habitually seek the sample source.
Habit 7: View Science as a Cumulative Process
A single study, no matter how elegant or seductive, is rarely definitive. Science is a cumulative process that requires a large body of consistent and reproducible evidence before conclusions can be formed. 3~ When we interpret an exciting set of data, the cumulative basis of science is often overshadowed by the seemingly irrefutable evidence at hand. At least until a new study, by different investigators in a different environment, adds a new twist.
Habit 7 is the process of integration: reconciling results with the existing corpus of known similar research. It is the natural consequence of Habits 1 through 3, which deal with description, and Habits 4 through 6, which deal with analysis. Thus data interpretation can be reduced to three words: describe, analyze, and integrate.
Research integration begins by asking "Do the results make sense?" Statistically significant findings that are biologically implausible, or that are inconsistent with other known studies, can often be explained by hidden biases or design flaws that were initially unsuspected (Habit 1). Improbable results can become statistically significant through biased data collection, natural history, placebo effects, unidentified confounding variables, or improper statistical analysis. A study with design flaws or improper statistical analysis is said to have low internal validity (Table 11 ) and should be reanalyzed or discarded.
At the next level of integration, we compare the study design that produced the current data with the design of other published studies. The level of evidence generally increases as we progress from uncontrolled observational studies (case reports, case series) to controlled observational studies (cross-sectional, retrospective, prospective) to controlled experiments (randomized trials). For example, if several randomized efficacy trials have already been published about the topic of interest, an uncontrolled study is unlikely to provide any new insights. When a certain level of evidence has been accumulated, causation may be inferred. Causation is an epidemiologic concept based on the consistency, strength, specificity, temporal relation, and dose/response relation of the association between a factor and a particular disease or outcome. 31 Quantitative data integration ranges from simple tabular listings to systematic reviews suitable for publication as original research. A simple table summarizing results of the current study and related studies is a good starting point. Unfortunately, authors of a new and exciting randomized trial often view their results as the "bottom line" and spend little time reconciling it with other prior studies. Systematic reviews or meta-analyses are an ideal way to synthesize results from a group of logically related randomized trials or, less commonly, observational studies. 32 The bottom line in a systematic review typically includes a summary measure of effect size (e.g., rate difference), a 95% confidence interval, and a statistical test for heterogeneity among source articles. Other types of integrative studies include practice guidelines, decision analysis, and economic (cost benefit) analysis.
Hippocrates cautioned "Foolish is the doctor who despises the knowledge acquired by the ancients." As journal articles continue their exponential proliferation, "ancient" may be as recent as last month's publications. The effective data user views science as a cumulative process and specializes in the archaeology of literature review. Fortunately, computer access to the literature is proliferating faster than the literature it accesses, making it inexcusable to ignore "the knowledge acquired by the ancients."
PUTTING PRINCIPLES INTO PRACTICE
My goal has been to show that effective interpretation of medical data involves much more than statistics or numeric formulae. Rather it is a systematic process of moving from observations to generalizations with predictable degrees of certainty (and uncertainty). Every physician is involved in this process to some extent, whether a solo practitioner in a rural community or a full-time academician in a large university. The same process applies to interpreting our own data, interpreting someone else's data (e.g., a journal article), reviewing an unpublished manuscript for a journal, or reviewing a grant application for a funding agency.
The seven habits listed in Table 1 provide a systematic framework for interpreting data, of which statistical tests are only a small part. Although Habit 4 (measure error with the right statistical test) generates p values, it is sandwiched between Habits 1 through 3 and Habits 5 through 7. p Values are part of the process but represent neither the beginning nor the end. We begin by verifying that the data are of sufficient quality and precision to merit statistical analysis (Habits 1 through 3). We end by seeking clinically significant findings that can be generalized beyond the study and are consistent with prior knowledge and experience (Habits 5 through 7). Obsession with p values, which has been called the "religion of statistics," may produce publications but rarely achieves effective data interpretation. 33 Every clinician need not be a statistician, but all should understand the fundamental principles of data analysis and interpretation. When understood and applied, the habits in Table 1 will permit intelligent, synergistic dialogue between clinicians and statisticians. Such dialogue ideally precedes any serious research endeavor, because even the most elegant statistics cannot adjust for biased data or confounders that were never measured. 34 The statistician excels at analyzing data the right way, but the clinician's leadership ensures that the right data are analyzed. Further, clinical importance (Habit 5) is best determined by clinicians, not statisticians.
Hoping to have lit the fires of inferential desire, I end by summarizing some good sources of firewood. A Dictionary of Epidemiology by Last 35 is an indispens-
